Back to Search Start Over

The role of myeloid-derived immunosuppressive cells in cardiovascular disease.

Authors :
Li, Qingmei
Mei, Aihua
Qian, Hang
Min, Xinwen
Yang, Handong
Zhong, Jixin
Li, Chunlei
Xu, Hao
Chen, Jun
Source :
International Immunopharmacology. Apr2023, Vol. 117, pN.PAG-N.PAG. 1p.
Publication Year :
2023

Abstract

• Previous studies have focused more on the role of MDSCs in diseases such as tumors, and this review comprehensively summarizes the role of MDSCs in the field of cardiovascular diseases. • The latest literature was reviewed to describe the source, phenotype, and immunosuppressive function of MDSCs. • Comprehensively summarizes the research progress of MDSCs in common cardiovascular diseases such as atherosclerosis, acute coronary syndrome, hypertension, myocarditis, heart failure, and dilated cardiomyopathy. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population found in the bone marrow, peripheral blood, and tumor tissue. Their role is mainly to inhibit the monitoring function of innate and adaptive immune cells, which leads to the escape of tumor cells and promotes tumor development and metastasis. Moreover, recent studies have found that MDSCs are therapeutic in several autoimmune disorders due to their strong immunosuppressive ability. Additionally, studies have found that MDSCs have an important role in the formation and progression of other cardiovascular diseases, such as atherosclerosis, acute coronary syndrome, and hypertension. In this review, we will discuss the role of MDSCs in the pathogenesis and treatment of cardiovascular disease. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15675769
Volume :
117
Database :
Academic Search Index
Journal :
International Immunopharmacology
Publication Type :
Academic Journal
Accession number :
162758156
Full Text :
https://doi.org/10.1016/j.intimp.2023.109955